Femme et Homme
- | Pays :
- China
- Korea, Republic of
- Taiwan, Province of China
- | Organes : -
- | Spécialités : -
Extrait
This study will evaluate the antiviral efficacy of ledipasvir (LDV)/sofosbuvir (SOF) fixed-dose combination (FDC) in treatment-naive and treatment-experienced participants with chronic genotype 1 Hepatitis C Virus (HCV) infection. Participants will receive 12 weeks of treatment and continue assessments during a 24-week follow-up period.
Critère d'inclusion
- Chronic HCV Infection